S-1 EX-FILING FEES 0001139685 N/A N/A 0001139685 1 2026-04-03 2026-04-03 0001139685 2 2026-04-03 2026-04-03 0001139685 3 2026-04-03 2026-04-03 0001139685 4 2026-04-03 2026-04-03 0001139685 2026-04-03 2026-04-03 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

20/20 BIOLABS, INC.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common Stock, $0.01 par value, issued to the selling stockholder   (1)   457(a)   475,000   $ 1.81   $ 859,750.00   0.0001381   $ 118.73
Fees to be Paid   Equity   Common Stock, $0.01 par value, issuable to the selling stockholder upon conversion of secured convertible promissory note   (2)   457(a)   42,500     1.81     76,925.00   0.0001381     10.62
Fees to be Paid   Equity   Common Stock, $0.01 par value, issuable to the selling stockholder upon exercise of outstanding warrants   (3)   457(a)   62,500     1.81     113,125.00   0.0001381     15.62
Fees to be Paid   Equity   Common Stock, $0.01 par value, that may be issued to the selling stockholder upon the conversion of shares of series E convertible preferred stock that may be issued to the selling stockholder   (4)   457(a)   9,525,000   $ 1.81   $ 17,240,250.00   0.0001381   $ 2,380.88
                                           
Total Offering Amounts:   $ 18,290,050.00         2,525.85
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 2,525.85

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.
(2) Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.
(3) Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.
(4) Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering hereunder an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions. The Proposed Maximum Offering Price Per Unit was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market on April 2, 2026.